###begin article-title 0
Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate
###end article-title 0
###begin p 1
Conceived and designed the experiments: KY LAMR. Performed the experiments: KY OA VS AS ACB GGT. Analyzed the data: KY OA VS AS GGT CMD AB FE LAMR. Contributed reagents/materials/analysis tools: VZ TV RK GW JO LAMR. Wrote the paper: KY OA CMD AB FE LAMR.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 372 375 <span type="species:ncbi:9606">men</span>
The conversion of soluble peptides and proteins into polymeric amyloid structures is a hallmark of many age-related degenerative disorders, including Alzheimer's disease, type II diabetes and a variety of systemic amyloidoses. We report here that amyloid formation is linked to another major age-related phenomenon - prostate tissue remodelling in middle-aged and elderly men.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 662 669 662 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 841 857 841 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 841 857 <span type="species:ncbi:562">Escherichia coli</span>
By using multidisciplinary analysis of corpora amylacea inclusions in prostate glands of patients diagnosed with prostate cancer we have revealed that their major components are the amyloid forms of S100A8 and S100A9 proteins associated with numerous inflammatory conditions and types of cancer. In prostate protease rich environment the amyloids are stabilized by dystrophic calcification and lateral thickening. We have demonstrated that material closely resembling CA can be produced from S100A8/A9 in vitro under native and acidic conditions and shows the characters of amyloids. This process is facilitated by calcium or zinc, both of which are abundant in ex vivo inclusions. These observations were supported by computational analysis of the S100A8/A9 calcium-dependent aggregation propensity profiles. We found DNA and proteins from Escherichia coli in CA bodies, suggesting that their formation is likely to be associated with bacterial infection. CA inclusions were also accompanied by the activation of macrophages and by an increase in the concentration of S100A8/A9 in the surrounding tissues, indicating inflammatory reactions.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
These findings, taken together, suggest a link between bacterial infection, inflammation and amyloid deposition of pro-inflammatory proteins S100A8/A9 in the prostate gland, such that a self-perpetuating cycle can be triggered and may increase the risk of malignancy in the ageing prostate. The results provide strong support for the prediction that the generic ability of polypeptide chains to convert into amyloids could lead to their involvement in an increasing number of otherwise apparently unrelated diseases, particularly those associated with ageing.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Untergasser1">[1]</xref>
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-DeMarzo1">[2]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-DeMarzo1">[2]</xref>
###xml 767 770 767 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Varenhorst1">[3]</xref>
###xml 772 775 772 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Adolfsson1">[4]</xref>
###xml 1459 1462 1459 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Adolfsson1">[4]</xref>
###xml 216 219 <span type="species:ncbi:9606">men</span>
###xml 330 333 <span type="species:ncbi:9606">men</span>
###xml 467 470 <span type="species:ncbi:9606">men</span>
The reproductive role of the prostate gland decreases with increasing age, leading to prostate tissue remodelling. This can be accompanied by serious problems such as benign prostatic hyperplasia, observed in 70% of men in their 60 s [1], and prostate cancer [2]. The latter is the most common non-cutaneous malignant neoplasm in men in Western countries [2]. The incidence of prostate cancer is rising rapidly with ageing population and now affects several millions men in Western world. In USA alone ca. 190 000 new cases are reported yearly and ca. 29 000 deaths have occurred from prostate cancer in 2008 according to the surveillance of the National Cancer Institute. In Europe mortality rates from prostate cancer varies significantly among different countries [3], [4]. There is a marked contrast between Mediterranean regions with below-average mortality and the other states, where there are several canters of excess mortality, including Sweden, Denmark, West of Germany, North of France, Ireland and Netherlands. There is a lack of understanding of the factors which may affect the increasing incidence of disease and its obvious geographic pattern. It appears that prostate pathologies may be a cost of longevity in the post-reproductive period. In order to provide an insight into the potential causes of prostate pathologies, we have carried out systematic and multidisciplinary studies of common prostate inclusions denoted as corpora amylacea [4], which are found in a significant proportion of males over the age of 50.
###end p 9
###begin p 10
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Untergasser1">[1]</xref>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-DeMarzo1">[2]</xref>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Coussens1">[5]</xref>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-DeMarzo1">[2]</xref>
###xml 419 422 419 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Jager1">[6]</xref>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Christian1">[7]</xref>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Bostwick1">[8]</xref>
###xml 836 839 836 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hoyaux1">[9]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Rocken1">[10]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Shintaku1">[11]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Rocken1">[10]</xref>
###xml 976 979 976 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hoyaux1">[9]</xref>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Gati1">[13]</xref>
###xml 1151 1154 1151 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hoyaux1">[9]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cisse1">[14]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Chung1">[15]</xref>
###xml 1349 1353 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Gati1">[13]</xref>
###xml 1355 1359 1355 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Singhrao1">[16]</xref>
###xml 219 224 <span type="species:ncbi:9606">human</span>
###xml 1039 1047 <span type="species:ncbi:9606">patients</span>
There is a growing body of evidence indicating that inflammation plays a crucial role in prostate pathogenesis, as it is found to be associated with 40-90% of benign prostatic hyperplasia [1] as well as with 20% of all human cancers [2], [5]. CAs are thought to be linked clinically to asymptomatic prostate inflammation and are often observed adjacent to the damaged epithelium and focal inflammatory infiltrates [2], [6], [7]. CAs have been also detected in 55% of cases in a study of high-grade prostatic intraepithelial neoplasia in specimens derived from radical prostatectomies [8]. The prostate CA depositions are often of a few millimetres in diameter, but their bulk weight can in some instances constitute up to a third of the weight of the prostate gland. The inclusions bodies coined as CA have been also found in the brain [9], lung [10], ovary [11] and uterus [10]. Their incidence is commonly associated with ageing and they may be of a very diversified origin [9]-[13]. Brain CAs have been observed much more frequently in patients suffering from Alzheimer's disease and other neurodegenerative conditions rather then in normal ageing [9], [14], [15]. Indeed, it has been suggested that in the development of CA in the brain, the initiating process is most probably degenerative in nature, following the synthesis of stress proteins [13], [16].
###end p 10
###begin p 11
###xml 62 66 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cross1">[17]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cross1">[17]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Marx1">[19]</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Klimas1">[20]</xref>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Thomas1">[21]</xref>
###xml 599 603 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Drach1">[22]</xref>
###xml 864 867 864 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Jager1">[6]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Jun1">[23]</xref>
###xml 875 879 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Singh1">[24]</xref>
###xml 1065 1069 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Rocken1">[10]</xref>
###xml 1071 1075 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cross1">[17]</xref>
###xml 1081 1082 1078 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1454 1458 1451 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Solomon1">[25]</xref>
###xml 773 778 <span type="species:ncbi:9606">human</span>
###xml 779 787 <span type="species:ncbi:9606">patients</span>
Despite the high prevalence of the prostate CAs in later life [17], this is still a highly disputed area with regard to their nature and pathological significance in normal ageing and in prostate pathologies resulting from benign or malignant changes. In several early studies it was reported that prostatic CAs could contain amyloid structures [17]-[19]; however CAs were also viewed as calcified bodies, prostatic concretion or calculi, resulting from calcification of precipitated prostatic secretion [20], [21] or arising from simple precipitation of salts normally presented in prostatic fluid [22]. Localized amyloid deposits, which were not defined as CA, have been also described in prostate, seminal vesicles and in the lower urinary tract in some case studies on human patients by using clinical, radiological, MRI and immunohistopathological techniques [6], [23], [24]. The protein content of some prostate CA inclusions was investigated by immunohistochemical staining using a panel of antibodies against the major known in 1990s amyloidogenic proteins [10], [17]; beta2-microglobulin was identified, but the antibodies to other proteins, which were not known as amyloidogenic thus far, have not been subjected to this examination. Besides this, the application of immunostaining as a sole method to detect proteins proved to be unreliable, especially if potential candidates may be present not in the native state, but in their amyloid form [25].
###end p 11
###begin p 12
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Schafer1">[26]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Heizmann1">[27]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Foell1">[28]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Gebhardt2">[30]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Gebhardt1">[29]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Emberley1">[31]</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Ott1">[33]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hermani1">[34]</xref>
###xml 969 973 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hermani2">[35]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hermani2">[35]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hofmann1">[36]</xref>
###xml 1448 1452 1448 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-McCormick1">[37]</xref>
###xml 1626 1629 1626 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Hoyaux1">[9]</xref>
###xml 1847 1851 1847 1851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Leukert1">[38]</xref>
###xml 1852 1856 1852 1856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Nacken1">[41]</xref>
###xml 2093 2100 2093 2100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2105 2113 2105 2113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 746 751 <span type="species:ncbi:9606">human</span>
###xml 935 940 <span type="species:ncbi:9606">human</span>
###xml 1607 1612 <span type="species:ncbi:9606">human</span>
In the present work we have characterized CA inclusions extracted from seven radical prostatectomy specimens from human patients diagnosed with prostate cancer. By using a range of modern biochemical and biophysical techniques we have shown that the pro-inflammatory calcium-binding proteins S100A8 and S100A9, also known as calgranulin A and calgranulin B, respectively, play an important role in their formation. The S100A8 and S100A9 belong to a multigenic and multifunctional family of about 20 members of calcium-binding S100 proteins [26], [27]. A heterodimer of S100A8/A9 has emerged as an important pro-inflammatory mediator in acute and chronic inflammation [28]-[30]. Increased levels of S100A8 and S100A9 have been detected in various human cancers, being abundantly expressed in neoplastic cells and also in infiltrating immune cells [29], [31]-[33]. In particular, the enhanced secretion of S100A8 and S100A9 was found in human prostate cancer cells [34], [35]. Altogether, their expression patterns, potential cytokine-like functions, up-regulation and regulation via signalling pathways, including tumor-promoting RAGE receptor, suggest that S100A8/A9 may play a key role in inflammation-associated cancers [35], [36]. Moreover, emerging evidence revealed a general role for the S100A9 protein in the phenomenon of dystrophic calcification, specifically in calcifying matrix vesicles and atherosclerotic plaques in the arterial wall [37]. It is interesting to note, that nine out of ten immunohistochemically analyzed S100 proteins of the S100 family were also found in CA deposits in normal human brain tissue [9]. The S100A8 and S100A9 molecules are characterized by a conformational variability, adopting hetero and homo-dimeric, trimeric as well as tetrameric complexes, that can also contribute to their multiple functionality [38]-[41]. Although many functions have been identified and proposed for S100A8/A9, their roles in various biological processes still remain to be defined. For the first time we report that S100A8/A9 proteins readily form amyloid structures both in vivo and in vitro and they are present in the prostate CA inclusions in their amyloid form.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Protein identification in CA inclusions by mass-spectrometry
###end title 14
###begin p 15
###xml 199 206 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t001">Table 1</xref>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t001">Table 1</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t002">2</xref>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 455 462 <span type="species:ncbi:9606">patient</span>
###xml 466 473 <span type="species:ncbi:9606">patient</span>
In order to identify the specific proteins within CA, the samples were solubilized in ice cold TE buffer and analyzed by liquid chromatography coupled with electrospray ionization mass-spectrometry (Table 1). In all the specimens examined the data reveal the presence of 3 major proteins, S100A8, S100A9 and human serum albumin. A several auxiliary and bacterial proteins were also identified (Table 1 and 2), but these proteins varied substantially from patient to patient and their quantities were too low to be detected by subsequent gel electrophoresis with silver staining.
###end p 15
###begin title 16
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Proteins identified in CA samples from the selected group of patients by liquid chromatography-electrospray ionization mass spectrometry.
###end title 16
###begin p 17
Calculated after removing signal peptide from their precursor sequence. # No significant identification.
###end p 17
###begin title 18
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
###xml 18 25 <span type="species:ncbi:562">E. coli</span>
Escherichia coli (E. coli) proteins identified in CA samples by liquid chromatography-electrospray ionization mass spectrometry.
###end title 18
###begin p 19
A single peptide from each protein was identified.
###end p 19
###begin title 20
Presence of bacteria in CA inclusions
###end title 20
###begin p 21
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Harris1">[42]</xref>
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005562.s001">Figure S1</xref>
###xml 380 396 380 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 516 532 516 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t002">Table 2</xref>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 380 396 <span type="species:ncbi:562">Escherichia coli</span>
###xml 426 446 <span type="species:ncbi:77133">uncultured bacterial</span>
###xml 516 532 <span type="species:ncbi:562">Escherichia coli</span>
The CA samples from 5 patients were further analyzed for the presence of bacterial DNA by the polymerase chain reaction (PCR) method [42]. Bacterial 16s rDNA was detected in all specimens (Figure S1). The PCR products were cloned and 5 clones from each specimen were sequenced. Altogether, 13 distinct sequences (323-338 bps) were identified, 8 of which shared >98% homology with Escherichia coli sequences, 3 corresponded to uncultured bacterial clones and 2 showed <98% homology to published sequences. 4 out of 5 Escherichia coli rDNA positive samples have been shown also to contain bacterial proteins (Table 2).
###end p 21
###begin title 22
Amyloid nature of the major proteinaceous components of CA
###end title 22
###begin p 23
###xml 185 194 185 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1A</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Leukert1">[38]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Vogl1">[40]</xref>
###xml 343 352 343 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1A</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Leukert1">[38]</xref>
###xml 517 521 517 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Vogl1">[40]</xref>
###xml 987 996 987 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1A</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 523 528 <span type="species:ncbi:9606">Human</span>
The extracts from the CA samples were subjected to SDS-PAGE electrophoresis and then to Western blot analysis with polyclonal antibodies towards S100A8, S100A9 and human serum albumin (Figure 1A). The S100A9 antibodies recognized 14 kDa monomeric and 28 kDa dimeric species [38]-[40], the S100A8 antibodies recognized 10 kDa monomeric S100A8 (Figure 1A) in 3 out of 7 specimens analyzed. Both the S100A8 and S100A9 antibodies recognized a 48 kDa species, suggesting the presence of hetero-tetramers of S100A8/A9 [38]-[40]. Human serum albumin antibodies interacted with a ca. 50 kDa molecular species, indicating the presence of truncated serum albumin (the molecular weight of the intact protein is 67 kDa). However, aggregated species with a high molecular weight, and which remained in the stacking gels, did not interact with anti-serum albumin antibodies. They were stained by both S100A8 and S100A9 antibodies, indicating that these aggregates are composed of both these proteins (Figure 1A).
###end p 23
###begin title 24
Immunoassays of CA proteinaceous components.
###end title 24
###begin p 25
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 683 688 <span type="species:ncbi:9606">human</span>
(A) Western blots of CA extracts from three representative specimens with S100A9, S100A8 and human serum albumin antibodies; the staining of aggregates in stacking gel with corresponding antibodies is shown in the right column. (B and C) Immunostaining of CA and surrounding tissues with S100A8 and S100A9 antibodies, respectively, shown in brown; the positive S100A8/A9-staining of CA (1), macrophages in stroma (2), macrophages in epithelium tissues (3) and the focal epithelial staining (4) are indicated by numbers and arrows. (D) Co-immunostaining of CA inclusions with anti-S100A8 (shown in purple) and anti-S100A9 antibodies (shown in brown). (E) Lack of CA immunostaining by human serum albumin antibodies (CA body does not display purple colour). (F and G) Immunostaining of the prostate CA inclusions by antibodies towards amyloid fibrils shown in purple with low and high magnification. The magnification is indicated in left lower corner of each image.
###end p 25
###begin p 26
###xml 156 168 156 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1B&#8211;1D</xref>
###xml 396 412 396 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1B and 1C</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1D</xref>
###xml 700 709 700 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1E</xref>
###xml 934 938 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Kayed1">[43]</xref>
###xml 940 956 940 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1F and 1G</xref>
###xml 1049 1058 1049 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005562.s002">Figure S2</xref>
The CA samples were also subjected to immunohistochemical analysis, which revealed that they are stained positively with both S100A8 and S100A9 antibodies (Figure 1B-1D). In the tissues adjacent to CA inclusions we observed positive foci of S100A8 and S100A9, including the S100A8 and S100A9 positively stained glandular epithelial cells and tissue macrophages, which infiltrate inflamed glands (Figure 1B and 1C). The co-immunostaining of CA inclusions with both antibodies towards S100A8 and S100A9 proteins is shown in Figure 1D with higher magnification. By contrast, only weak staining with serum albumin antibodies was observed at the edges of the CA inclusions and in the surrounding tissues (Figure 1E), indicating that serum albumin, detected by mass-spectrometry and Western blot analysis, came from the surrounding tissues, and not from the CA bodies. All CA specimens were also stained with anti-amyloid fibril antibodies [43] (Figure 1F and 1G) and with Congo red dye, used as a marker for the presence of the amyloid form of proteins (Figure S2). These results demonstrate that the amyloid material constitutes a significant mass of the CA specimens.
###end p 26
###begin title 27
Structural characterisation of S100A8/A9 amyloid formation
###end title 27
###begin p 28
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 199 207 199 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2</xref>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2A</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Kayed2">[44]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-MorozovaRoche1">[46]</xref>
###xml 575 591 575 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2B and 2O</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2C</xref>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2D</xref>
Atomic force microscopy (AFM) and transmission electron (TEM) microscopy were used to examine the ex vivo CA extracts, and they revealed the presence of a variety of highly heterogeneous aggregates (Figure 2). These aggregates include spherical species of ca. 2-3 nm in height (Figure 2A), some of them arranged into chain-like sequences, which were closely similar to the oligomeric precursors of amyloid fibrils described for numerous peptides and proteins [44]-[46]. Extensive networks of fibrillar species of 4-8 nm in height and several microns in length were observed (Figure 2B and 2O), characteristic of mature amyloid fibrils. Assemblies of straight and rigid fibrils a few hundred nanometres in length (Figure 2C) were present in all CA specimens, as well as there were larger scale super-molecular assemblies, reaching a few microns in length and up to ca. 500 nm in thickness (Figure 2D).
###end p 28
###begin title 29
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
AFM and TEM imaging of ex vivo and in vitro S100A8/A9 amyloid structures.
###end title 29
###begin p 30
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 665 666 641 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 671 672 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 691 692 667 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(A) AFM images of ex vivo amyloid oligomers, chain-like sequences are indicated by blue arrow; (B) ex vivo amyloid fibrillar network; (C,D) TEM images of ex vivo amyloid superstructures; (E) AFM images of S100A8/A9 oligomeric assemblies produced at pH 7.4, 37degreesC with agitation after 2 week of incubation, (F,G) fibrillar bundles produced at pH 7.4, 37degreesC with agitation after 8 weeks; (H-K) heterogeneous types of S100A8/A9 amyloids produced at pH 2.0 and 57degreesC after 4 weeks of incubation with residual content of Ca and Zn. S100A8/A9 amyloids produced at pH 2.0 and 57degreesC after 2 weeks of incubation in the presence of (L) 1 mg/ml powdered Ca3(PO4)2 and (M) 10 mM ZnCl2; (N) aggregates observed in the presence of 50 mM EDTA. AFM cross-section analysis of amyloid structures indicated by red lines in corresponding images (O from B; P from F and Q from I). Scale bars are shown in white and equal to 250 nm in all AFM images.
###end p 30
###begin p 31
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 220 236 220 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 576 580 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Vogl1">[40]</xref>
###xml 582 586 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-vandenBos1">[47]</xref>
###xml 714 721 702 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 800 809 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2E</xref>
###xml 991 1011 979 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2F, 2G and 2P</xref>
###xml 220 236 <span type="species:ncbi:562">Escherichia coli</span>
In order to examine further the amyloidogenic properties of the S100A8/A9 proteins we set out to produce their amyloid forms in vitro. The S100A8/A9 complexes, extracted from granulocytes and produced recombinantly from Escherichia coli, were each incubated under the native conditions of pH 7.4 and 37degreesC with agitation and at pH 2.0 and 57degreesC without agitation. The aliquots were collected regularly for further examination during the period of 2 months; the sub-millimolar concentrations of metal ions were present in the samples after the purification procedure [40], [47]. Under both conditions the proteins were found to assemble into heterogeneous fibrillar species. At pH 7.4, species resembling ex vivo oligomers and short protofilaments were observed after 2 weeks of incubation (Figure 2E). Upon further incubation for up to 8 weeks, thick bundles of fibrils with heights of 15-20 nm and a few microns in length constituted the major population of fibrillar aggregates (Figure 2F, 2G and 2P).
###end p 31
###begin p 32
###xml 129 138 129 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2H</xref>
###xml 229 245 229 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2I and 2Q</xref>
###xml 351 360 351 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2K</xref>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 408 417 408 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2C</xref>
###xml 476 485 476 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2J</xref>
###xml 531 540 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2D</xref>
In the S100A8/A9 samples incubated at pH 2.0 without agitation the spherical species and protofilaments also emerged in 2 weeks (Figure 2H), and after 4 weeks the flexible fibrils with height of ca. 4-5 nm and microns in length (Figure 2I and 2Q) were observed together with straight and rigid fibrillar structures a few hundred nanometres in length (Figure 2K), which resembled the ex vivo species shown in Figure 2C. Large fibrillar bundles, reaching ca. 80 nm in diameter (Figure 2J) and resembling the superstructures shown in Figure 2D, were also regularly found in specimens incubated for 4-6 weeks.
###end p 32
###begin p 33
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 270 271 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 276 277 276 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 279 295 279 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2L and 2M</xref>
###xml 373 382 373 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2N</xref>
As ex vivo CA deposits were found to be calcified and to contain zinc salts, we examined the effect of these ions on amyloid formation by S100A8/A9. The S100A8/A9 amyloid protofilaments of ca. 2 nm height were assembled in the presence of ZnCl2 and in a suspension of Ca3(PO4)2 (Figure 2L and 2M), but not when EDTA was added in solution even during 2 weeks of incubation (Figure 2N). These species converted into the fibrillar assemblies described above upon prolonged incubation, and again no filamentous structures developed in the presence of EDTA.
###end p 33
###begin title 34
Aggregation propensity profiles of S100A8/A9
###end title 34
###begin p 35
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Tartaglia1">[48]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Pawar1">[49]</xref>
###xml 363 371 363 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 466 474 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g003">Figure 3</xref>
###xml 783 787 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Tartaglia1">[48]</xref>
###xml 928 936 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g003">Figure 3</xref>
###xml 1525 1529 1519 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Leukert2">[39]</xref>
The identification of the regions of peptide and protein sequences, that are likely to be most important in promoting amyloid formation, enables us to predict the behaviour of these two proteins under given conditions. Intrinsic aggregation propensity profiles [48], [49] of monomeric S100A8 and S100A9 at pH 7.0 and pH 2.0, the conditions which we have used for in vitro amyloid formation, and in their natively folded S100A8/A9 oligomeric complex were calculated (Figure 3). The overall aggregation scores for S100A8 are 0.76 at pH 7.0 and 0.77 at pH 2.0 and for S100A9, 1.04 and 0.65, respectively; the aggregation score of S100A9 in particular is similar to the aggregation scores of Abeta(1-40) and Abeta(1-42) peptides at pH 7.0, which are equal to 0.97 and 0.94, respectively [48]. In the S100A8/A9 oligomeric complex (references for the structures: pdb 1xk4 for S100A8 and pdb 1irj for S100A9) the aggregation profiles (Figure 3) and the scores of 0.18 and 0.32 for S100A8 and S100A9, respectively, are significantly reduced, indicating that most of the aggregation-prone sequences are involved in the oligomeric interactions. In both proteins the calcium-binding sites with low affinity (amino acid residues 20-33 for S100A8 and 23-36 for S100A9) and high affinity (amino acid residues 59-70 for S100A8 and 67-78 for S100A9) are located in close proximity to the segments that are highly aggregation-prone. As S100A8 and S100A9 at neutral pH undergo a calcium-dependent oligomerization rather than amyloid formation [39] and as the intermolecular interactions responsible for native state oligomerization and aggregation can overlap, calcium-binding is likely to generate conformational changes that, in addition to promoting native state oligomerization, increase the aggregation process as demonstrated above. Hence, we surmise that the evolution of a calcium-dependent oligomerization required to generate the native functional state, has come at the cost of a higher calcium-dependent aggregation propensity.
###end p 35
###begin title 36
Intrinsic aggregation propensity profiles.
###end title 36
###begin p 37
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">turquoise</italic>
###xml 159 169 159 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue lines</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 250 255 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">black</italic>
###xml 278 287 271 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue bars</italic>
(A) S100A8 and (B) S100A9 aggregation propensity profiles denoted at pH 7.0 by red, at pH 2.0 - by turquoise and in the natively folded S100A8/A9 complex - by blue lines, respectively. Calcium-binding sites are indicated by green, alpha-helices - by black and beta-strands - by blue bars, respectively.
###end p 37
###begin title 38
Analysis of the mineral phases of CA
###end title 38
###begin p 39
###xml 184 193 184 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g004">Figure 4A</xref>
###xml 298 301 298 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3/2</sub>
###xml 321 324 321 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3/2</sub>
###xml 509 510 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 515 516 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 521 530 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g005">Figure 5A</xref>
###xml 551 552 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 557 558 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 561 570 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g005">Figure 5B</xref>
###xml 1906 1908 1898 1900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 2003 2005 1995 1997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 2020 2022 2012 2014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 2115 2124 2107 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g004">Figure 4B</xref>
###xml 1602 1610 <span type="species:ncbi:9606">patients</span>
In order to determine the mineral components of CA inclusions, the powdered CA samples were subjected to x-ray photoelectron spectroscopy (XPS) analysis. A typical XPS spectrum of CA (Figure 4A) reveals the presence of C, N, O, P, Ca, K, Zn and Mg atoms. The binding energies derived from the Ca 2p3/2 (347.4 eV) and P 2p3/2 (133.2 eV) lines and the Ca/P atomic ratio (1.3:1.0+/-0.2) indicate the presence of calcium phosphate phases as a major inorganic component of CAs. The existence of hydroxylapatite (Ca5(PO4)3OH) (Figure 5A) and whitlockite (Ca2(PO4)3) (Figure 5B) crystalline phases in various CA samples was also confirmed by x-ray powder diffraction measurement. The atomic concentrations of Zn (ca. 0.3 atomic %) and Mg (1.5-2.0 atomic %) indicate that these ions are incorporated into the calcium phosphate phases to form crystalline compounds, in which up to 20% of Ca cations are substituted by Zn or Mg. The atomic concentrations and binding energies corresponding to the photoelectron lines of N 1 s (NH, 400.0 eV, atomic concentration 5-6%), C 1 s (C-(C,H), 285.0 eV, atomic concentration ca. 13.5%; C-(O,N), 286.4 eV, atomic concentration ca. 5.7%; COOH, 288.1 eV, atomic concentration ca. 5.6%) and O 1 s (532.5 eV, atomic concentration ca. 6.9%) indicate that the remaining component of CA is proteinaceous in nature (NIST Standard Reference Database 20). A sample of CA was also probed at 350degreesC in an ashing furnace, which resulted in a 32% weight loss; this observation indicates that 30-40% of CA is organic in nature. XPS spectra recorded for the CA sample from different patients showed that the variation in the weight of mineral and organic compounds was within 10-20% and the variations in Zn content were within 0.1-0.5 atomic %. Consistent with the XPS analysis, the Fourier transform infrared spectrum of CA powder shows characteristic amide I-III bands of 1700-1359 cm-1, corresponding to peptide bonds in the proteinaceous phase, and the broad bands at 1100-900 cm-1 and 650-500 cm-1, which can be attributed to the vibration mode of the phosphate group in calcium phosphate (Figure 4B).
###end p 39
###begin title 40
Chemical content of CA inclusions.
###end title 40
###begin p 41
(A) XPS survey and (B) FTIR spectra of powdered prostate CA material.
###end p 41
###begin title 42
X-ray powder diffraction patterns of CA inclusions.
###end title 42
###begin p 43
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
(A) Hydroxylapatite - (Ca5(PO4)3OH) and (B) whitlockite - (Ca2(PO4)3) crystalline phases of CA.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Guevara1">[50]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Fung1">[51]</xref>
###xml 413 420 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t001">Table 1</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t002">2</xref>
###xml 454 455 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 537 541 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cross1">[17]</xref>
###xml 1285 1288 1282 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Varenhorst1">[3]</xref>
###xml 1290 1293 1287 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Adolfsson1">[4]</xref>
The results described in this study demonstrate that the prostate CA inclusions are primarily composed of calcified amyloid forms of the pro-inflammatory S100A8/A9 proteins. As prostatic fluid is very rich in protein content [50], [51], it is not unexpected that small quantities of a range of other proteins were also found in the CA inclusions, presumably being trapped in the aggregating and growing deposits (Table 1 and 2). We have not detected beta2-microglobulin reported previously in CA deposits by immunohistochemical analysis [17], even through we were able to detect small traces of bacterial proteins due to the high sensitivity of the liquid chromatography-electrospray ionization mass spectrometry technique, utilized in this study. We have investigated here the CA inclusions from the Scandinavian population; although probability cannot be excluded that prostate CA deposits can be diversified in their origin, depending on ethnic and geographical factors as well as their clinical history. Extended epidemiological studies on the male populations from different geographical and climate zones would be of significance in addressing this issue as well as in revealing the causative factors affecting the geographic pattern of prostate cancer incidence discussed above [3], [4].
###end p 45
###begin p 46
###xml 143 159 143 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g001">Figure 1B and 1C</xref>
###xml 493 501 493 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g006">Figure 6</xref>
In inflamed tissues adjacent to the CA inclusions we have commonly observed S100A8 and S100A9 positive focal epithelial cells and macrophages (Figure 1B and 1C). These activated cells may contribute to the rise in the concentrations of S100A8 and S100A9 at the sites of inflammation. As amyloid formation is a concentration-dependent process, the increasing concentration of aggregation-prone proteins in the sites of inflammation would favour their amyloid assembly and deposition in the CA (Figure 6).
###end p 46
###begin title 47
Inflammation-dependent pathways of the prostate CA formation.
###end title 47
###begin p 48
Infection, inflammation and amyloid self-assembly of S100A8/A9 proteins in the presence of calcium or/and zinc are important factors leading to CA depositions in the prostate gland.
###end p 48
###begin p 49
###xml 15 31 15 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 37 46 37 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005562.s001">Figure S1</xref>
###xml 52 68 52 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005562-t002">Table 2</xref>
###xml 328 344 328 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Bergh1">[52]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Soto1">[54]</xref>
###xml 437 453 437 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 15 31 <span type="species:ncbi:562">Escherichia coli</span>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
###xml 328 344 <span type="species:ncbi:562">Escherichia coli</span>
###xml 437 453 <span type="species:ncbi:562">Escherichia coli</span>
The finding of Escherichia coli DNA (Figure S1) and Escherichia coli proteins (Table 2), in the CA deposits makes it possible to hypothesize that CA formation may be associated with bacterial infection, taking place in the prostate during the prolonged course of their initiation and growth. Indeed, we and others have detected Escherichia coli in the prostate tissues [52]-[54] Therefore the CA, entrapping biological molecules such as Escherichia coli DNA and proteins, may represent a snapshot of the prostate history with regards to bacterial infection affecting the prostate gland during their formation. As a CA grows and the inflammatory process spreads, neighbouring acini are obstructed and the cycle can continue.
###end p 49
###begin p 50
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Stefani1">[55]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Uversky1">[59]</xref>
###xml 905 908 902 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-DeMarzo1">[2]</xref>
###xml 910 913 907 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Coussens1">[5]</xref>
###xml 915 918 912 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Christian1">[7]</xref>
Other amyloid diseases are known to be associated with chronic inflammation, including Alzheimer's and Parkinson's diseases, although it is far from clear, which role multifunctional inflammatory mediators play in different pathophysiological situations [55]-[59]. Growing evidence indicates that an abnormal deposition of fibrillar Abeta peptide in the brain can be accompanied by inflammatory responses and increasing production of pro-inflammatory cytokines in microglia. Amyloid formation by the pro-inflammatory S100A8/A9 proteins, their deposition in the ageing prostate and their association with local inflammatory reactions, all emphasise the role of persistent inflammation in the prostate pathogenesis. Growing CA deposits may induce further degradation of epithelial tissue in the prostate gland, exacerbating inflammation and, therefore, potentially contributing to neoplastic transformation [2], [5], [7]. Studies on a larger number of prostate samples, including both neoplastic and non-cancerous prostate, would further clarify this issue and should generate a link between the pathological cascade including infection, inflammatory response and amyloid deposition with benign and malignant transformations in the prostate gland.
###end p 50
###begin p 51
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Higurashi1">[60]</xref>
###xml 299 307 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g006">Figure 6</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Otzen1">[61]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Itzhaki1">[63]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Munch1">[64]</xref>
###xml 1035 1051 1035 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 1067 1091 1067 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 1169 1173 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Lundmark1">[65]</xref>
###xml 1312 1316 1312 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Wozniak1">[62]</xref>
###xml 1318 1322 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Itzhaki1">[63]</xref>
###xml 1504 1511 1504 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1557 1561 1557 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Fowler1">[66]</xref>
###xml 1563 1567 1563 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Cherny1">[67]</xref>
###xml 1978 1982 1978 1982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Tanaka1">[68]</xref>
###xml 566 569 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 583 589 <span type="species:ncbi:9606">humans</span>
###xml 1035 1051 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1067 1091 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1141 1147 <span type="species:ncbi:10090">murine</span>
###xml 1354 1381 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
The identification of bacterial DNA and proteins in CA, including the highly amyloidogenic co-chaperonin GroES [60], can be related not only to the fact that bacterial infection is a contributory factor to inflammation, but suggests the potential role of bacterial infection in amyloid depositions (Figure 6). Currently, the link between amyloid formation and bacterial and viral infections receives growing attention [61]-[63]. In particular, it has been shown that semen-derived amyloid fibrils of the fragments of prostatic acidic phosphatase drastically enhance HIV infection in humans [64]. It would be important to examine whether the amyloid structures of S100A8/A9 proteins in prostate may act as a seed, promoting the amyloid formation of prostatic acidic phosphatase fragments in prostatic fluid. It is not excluded that the amyloid structures of bacterial origin such as amyloidogenic chaperonin GroES may also contribute to amyloid seeding of S100A8/A9 proteins themselves. Indeed, it has been demonstrated that curli from Escherichia coli and Sup35 from Saccharomyces cerevisiae can exert amyloid-accelerating properties in the murine serum AA amyloidosis [65]. The biochemical link between viral infection and the development of the Alzheimer's disease pathological features has also been examined [62], [63] and the authors suggested that herpes simplex virus type 1 can directly contribute to the development of senile plaques. While the amyloid fibrils in bacteria, fungi insects and in de novo design were found to fulfil useful functions [66], [67], amyloidogenesis in general still requires tight regulation to avoid amyloid toxicity. In most cases amyloid fibrils are detrimental in the host, leading to pathologies. Due to their high potency in seeding and cross-seeding, the misfolding of proteins into an amyloid state can be a general origin of infectivity, which was highlighted in the phenomenon of amyloid formation and propagation by prion proteins [68].
###end p 51
###begin p 52
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Nacken1">[41]</xref>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 532 540 532 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g002">Figure 2</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Zhao1">[69]</xref>
###xml 932 936 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Nacken1">[41]</xref>
The hetero-oligomeric complexes of S100A8/A9 are characterised by significant stability and protease resistance comparable to these of prions [41]. In the protease rich environment of prostate gland, and especially at sites of inflammation, proteases are present at even higher levels than in other tissues. Protease resistance of the S100A8/A9 proteins could favour their accumulation and conversion into amyloid structures in prostate tissue. The bundles of amyloid fibrils of S100A8/A9 proteins, that are formed both in vivo and in vitro (Figure 2), are amongst the largest super-molecular species reported for amyloid assemblies [69]. The lateral association or thickening of the fibrils is likely to be a contributory factor to their stability in the prostate gland. Indeed, it has been suggested that the various functions of the S100A8/A9 hetero and homo-oligomers may be regulated by their differential protease sensitivity [41]. If so, the amyloid structures formed by the S100A8/A9 will be at the extreme end of the scale of resistance to proteolysis.
###end p 52
###begin p 53
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-McCormick1">[37]</xref>
###xml 263 272 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g004">Figure 4A</xref>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1082 1090 1082 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g006">Figure 6</xref>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
A recently reported function of S100A9 is associated with the promoting calcification [37], suggesting that this protein may also play a role in dystrophic calcification of CA deposits. The mineral content of CA was rather uniform in all the patients we studied (Figure 4A), suggesting that calcification is a regulated process and therefore could be influenced by the activities of S100A8/A9. In our in vitro studies we have shown that the formation of the amyloid structures of the S100A8/A9 proteins is promoted by the presence of calcium and zinc. The experimental observations were also supported by computational analysis of aggregation propensity profiles, demonstrating that the aggregation-prone regions are located in close proximity to the calcium- binding sites in both proteins. In the case of the S100A8/A9 proteins calcium-binding affects the competitive processes of protein folding and aggregation, while proteins themselves influence the process of calcification, which together may produce a synergistic effect, leading to the further enlargement of CA deposits (Figure 6).
###end p 53
###begin p 54
###xml 219 227 219 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005562-g006">Figure 6</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Chiti1">[70]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Dobson1">[71]</xref>
Thus, the direct involvement of pro-inflammatory S100A8/A9 proteins in CA biogenesis, which we reported here for the first time, emphasizes their role in the age-dependent prostate remodelling and accompanied ailments (Figure 6). The discovery of the link between amyloid formation and prostate pathogenesis supports the paradigm that the generic ability of polypeptides to assembly into this stable form as an alternative to the native state [70], [71] is likely to result in its involvement in an increasing number of age-related diseases. The disorders as apparently unrelated as Alzheimer's and Parkinson's diseases and prostate pathologies can all be linked by the common phenomenon of amyloid formation. In all these diversified diseases inflammation can be an important causative factor in amyloid depositions. This conclusion gives further support to the strategies aiming at averting inflammation in order to treat and possibly prevent amyloid formation and also potential neoplastic developments in prostate.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
CA specimens
###end title 56
###begin p 57
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
CA specimens were dissected from the prostate tissue from seven patients undergoing radical prostatectomy due to prostate cancer. All patients gave their written informed consent and the collection of human tissues was approved by the Umea research ethics board. The specimens were washed in sterile PBS and stored at -80degreesC.
###end p 57
###begin title 58
Protein samples
###end title 58
###begin p 59
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-vandenBos1">[47]</xref>
###xml 177 193 177 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Vogl1">[40]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 177 193 <span type="species:ncbi:562">Escherichia coli</span>
Human S100A8/A9 proteins were isolated from granulocytes as a heterodimer and stored in 20 mM Tris, 1 mM DTT, pH 7.2 [47]. Recombinant human S100A8 and S100A9 were expressed in Escherichia coli, their complex was produced as described previously [40] and they were kept in 20 mM Hepes, 140 mM NaCl, pH 7.4. The amyloid was produced by incubation of both purified from granulocytes S100A8/A9 complexes at 3.5 mg /ml and recombinant S100A8/A9 complexes at 2.3 mg/ml in 50 mM HCl, pH 2.0, 57degreesC without agitation and in the original buffers at pH 7.2 (pH 7.4), 37degreesC with agitation. All reagents were purchased from Sigma, unless stated otherwise.
###end p 59
###begin title 60
CA extractions
###end title 60
###begin p 61
###xml 187 191 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Nelson1">[72]</xref>
CA specimens were incubated in undiluted methanol at 4degreesC overnight, washed 3 times and ground in a glass homogenizer, adding ice cold TE buffer (20 mM Tris-HCl, 10 mM EDTA, pH 7.5) [72]. The homogenized material was centrifuged at 15000 g in a mini-centrifuge (Eppendorf). The pellet was re-suspended 3-4 times in TE buffer, homogenized through a 21gauge needle of 2 ml syringe and centrifuged again. TE buffer was sterilized and only sterile needles and syringes were used during the extraction procedures. All supernatants containing proteins were collected and stored at -20degreesC.
###end p 61
###begin title 62
CA extract tryptic digestion and peptide analysis by liquid chromatography-electrospray ionization mass spectrometry
###end title 62
###begin p 63
###xml 23 24 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 27 28 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 348 349 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 352 353 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 768 772 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Thingholm1">[73]</xref>
CA extracts in 0.2 M NH4HCO3, 15 mM DTT were incubated at 95degreesC for 15 min, cooled to room temperature, mixed with 8 M urea and incubated for 1 h. Subsequently, the alkylation reaction was carried out at 37degreesC for 30 min in darkness in the presence of 80 mM iodoacetamide. Urea concentration was reduced to 0.8 M by diluting with 0.2 M NH4HCO3. Trypsin was added at 1:40 enzyme-to-substrate ratio and tryptic digestion was carried out overnight at 37degreesC. It was stopped by adding formic acid to the final concentration of 0.5%. The resulting peptides were lyophilized and re-suspended in 1% TFA. Then they were desalted by using a Poros 50 reverse-phase R2 material (PerSeptive Biosystems) prepared in a GELoader tip (Eppendorf) as described previously [73]. The peptides were eluted from the R2 micro-column by using 80% acetonitrile with 0.1% TFA, lyophilized and re-suspended in 0.1% formic acid.
###end p 63
###begin p 64
Subsequently, the tryptic peptides were subjected to a reversed-phase ultra-performance nano ACQUITY UPLCtrade mark system (Waters). Each peptide sample was concentrated in a C18 trap column with symmetry of 180 micromx20 mm, 5 microm and washed with 5% acetonitrile and 0.1% formic acid at 15 microl/min speed for 1 min. The samples eluted from the trap column were subjected to a C18 analytical column (75 micromx100 mm, 1.7 microm) at 600 nl/min flow speed, using 0.1% formic acid as a solvent A and 0.1% formic acid in acetonitrile as a solvent B in a gradient. The following gradients were applied: linear from 0 to 40% B in 25 min, linear from 40 to 80% B in 1 min, isocratic at 80% B in 1 min, linear from 80 to 5% B in 1 min and isocratic at 5% B for 7 min.
###end p 64
###begin p 65
###xml 317 321 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Backstrom1">[74]</xref>
The eluting analytes were sprayed into a Q-Tof Ultimatrade mark mass spectrometer (Waters) with the capillary voltage set to 2.6 kV and cone voltage to 40 V. The instrument was calibrated using MS/MS fragments of GluFib peptide (Sigma Aldrich) and the samples offset calibration was performed as described previously [74]. The acquisition of MS/MS spectra was performed with an automated data-directed switching between the MS and MS/MS modes using the instrument software (MassLynx V4.0 SP4). The three most abundant signals of a survey scan (400-1300 m/z range, 0.87 s scan time and 0.13 s inter-delay) were selected by charge state, and collision energy was applied accordingly for sequential MS/MS fragmentation scanning (50-2000 m/z range, 0.9 s scan time, 0.1 s inter-delay). ProteinLynx Global Server software (V2.2.5) was used to convert raw data to peak lists for database searching.
###end p 65
###begin p 66
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
The negative control measurements with the ice cold TE buffer and 0.2 M NH4HCO3, 15 mM DTT buffer used for dissolving CA material were performed. These solutions were subjected to the same procedures as the CA samples to exclude the general background level of contaminations.
###end p 66
###begin title 67
Protein identification by database analysis
###end title 67
###begin p 68
###xml 148 153 <span type="species:ncbi:9606">human</span>
Proteins were identified by a local version of Mascot search program V2.1.04 and Mascot Daemon application V2.1.6 (Matrix Science Limited, ), using human sequence library in the International Protein Index (IPI) database (IPI_human_20080409, 72,340 sequences). The following settings were used for the database search: trypsin-specific digestion with one missed cleavage allowed, carbamidomethylated cysteine set as fixed modification, oxidized methionine and deamidation in variable mode, peptide tolerance of 60 ppm and fragment tolerance of 0.1 Da. Peptides with Mascot ion scores exceeding the threshold for statistical significance of p<0.05 were selected and also re-processed manually to validate their significance.
###end p 68
###begin title 69
Western blot analysis
###end title 69
###begin p 70
###xml 511 517 <span type="species:ncbi:9986">rabbit</span>
###xml 523 528 <span type="species:ncbi:9606">human</span>
###xml 696 707 <span type="species:ncbi:3704">horseradish</span>
###xml 740 746 <span type="species:ncbi:9986">rabbit</span>
Gel electrophoreses were performed under reducing conditions by using 8-25% Phast gradient gels. Pre-stained molecular weight "SeeBlue" standards (Invitrogen) were included in each experiment. In Western blots, proteins were electro-transferred to nitrocellulose membranes by a Phast-system equipment (GE Healthcare). Non-specific reactivity was blocked by 5% non-fat milk in Tris-buffered saline, containing 0.05% Tween 20 (TBS-T) at 37degreesC for 1 h, washed 3x5 min with TBS-T and incubated with polyclonal rabbit anti-human S100A8, S100A9 (Santa Cruz) and serum albumin (Sigma) antibodies at 4degreesC overnight. The membranes were washed 3x5 min with TBS-T and incubated in the presence of horseradish peroxidase conjugated with anti-rabbit IgGs (GE Healthcare) at 1:5000 dilution in TBS-T containing 5% non-fat milk at 37degreesC for 1 h. The blots were washed 3x15 min with TBS-T and the immuno-reactive proteins were detected by using the enhanced chemiluminescence kit (GE Healthcare).
###end p 70
###begin title 71
Immunohistochemistry
###end title 71
###begin p 72
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Kayed1">[43]</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 189 195 <span type="species:ncbi:9986">rabbit</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 405 411 <span type="species:ncbi:9986">rabbit</span>
Archival prostate samples from patients with prostate cancer were dewaxed in xylene and dehydrated in ethanol series. After antigen retrieval in 10 mM Tris, pH 9.0 they were incubated with rabbit polyclonal anti-human S100A8, S100A9 (Santa Cruz) and serum albumin antibodies (Sigma). The CA samples were also stained with anti-amyloid fibril antibodies [43]. The immune reactivity was detected by an anti-rabbit IgG peroxidase Immpress reagent kit, followed by a Vector VIP or Vector DAB peroxidase substrate kits (Vector Laboratories Inc.). Negative controls were performed by substituting the primary antibodies with PBS or irrelevant antibody.
###end p 72
###begin title 73
16s rDNA PCR and sequencing
###end title 73
###begin p 74
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Harris1">[42]</xref>
CA aseptically removed from fresh prostatectomy samples were washed in sterile PBS prior to DNA extraction. DNA was purified by using E.Z.N.A. Blood DNA kit 11 (Omega Bio-TEK). 16s rDNA PCR and cloning were performed as described previously [42]. Plasmids were purified by using the QIAprep Spin miniprep kit (Qiagen) and sequenced by using the T3 primer (MWG Biotech AG). Database sequence matches to listed organisms were used to define a phenotype, if the closest match shared >98% similarity.
###end p 74
###begin p 75
Sensitivity of the PCR corresponded to 200 colony forming units/reaction, which is significantly higher than the general background level. Stringent anti-contamination precautions to control PCR contamination were undertaken in the laboratory environment. The PCR laboratory space has complied or exceeded standard recommendations for PCR research, including isolated setup areas with dedicated pipettes, small reagent and primer aliquots, and use of aerosol-resistant pipette tips. The buffer solutions involved in the study were subjected to PCR analysis as negative controls to exclude potential reagent or laboratory contamination.
###end p 75
###begin title 76
Atomic force and electron microscopy
###end title 76
###begin p 77
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Malisauskas2">[75]</xref>
AFM measurements were performed on a PICO PLUS 5500 microscope (Agilent) as described previously [75]. The structural dimensions were determined by cross-section analysis in height images. TEM samples were applied to Formvar-coated nickel grids (400 mesh), stained with 2% uranyl acetate and viewed in a Philips CEM 100 (FEI) microscope. Fibrillar dimensions were obtained directly from the micrographs.
###end p 77
###begin title 78
Optical microscopy
###end title 78
###begin p 79
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-MorozovaRoche2">[76]</xref>
The CA samples were stained with Congo red as described previously [76]. The samples were analysed under polarised light in an Olympus SZX10 stereo microscope (Olympus America Inc.) equipped with 20x GSWH20X eyepieces under 40-fold magnification.
###end p 79
###begin title 80
Protein aggregation propensity profiles
###end title 80
###begin p 81
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Tartaglia1">[48]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Pawar1">[49]</xref>
Intrinsic aggregation propensity profiles of S100A8/A9 proteins were calculated as described previously [48], [49] by using the pdb files of 1xk4 for S100A8 and 1irj for S100A9 from the Protein Data Bank.
###end p 81
###begin title 82
XPS spectrometry
###end title 82
###begin p 83
###xml 132 137 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</sub>
###xml 248 252 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005562-Leone1">[77]</xref>
###xml 342 344 338 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sub>
XPS spectra were recorded using a Kratos Axis Ultra DLD electron spectrometer (Kratos Analytical) equipped with a monochromated Al Kalpha x-ray source operating at 150 W, a hybrid lens system including magnetic lenses and with a charge neutraliser [77]. The CA samples were instantly frozen and transferred to the analysis chamber with 2-4x10-7 Pa base-vacuum, -150degreesC. The wide-scan spectra (160 eV pass energy) and high resolution spectra of all elements (20 eV pass energy) were acquired. The binding energy scale was referenced to the C 1 s line of aliphatic carbon set at 285.0 eV. The spectra were processed by using a Kratos software. X-ray powder diffraction measurements were conducted on a D8 Advance powder diffractometer (Bruker).
###end p 83
###begin title 84
Fourier transform infrared spectroscopy
###end title 84
###begin p 85
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
The infrared spectra of solid samples were collected using a diffuse reflectance cell (Harrick Scientific) and a IFS-66V/S spectrometer (Bruker). 300 spectra at a resolution of 4 cm-1 were averaged over 4000-370 cm-1 range.
###end p 85
###begin title 86
Thermogravimetry
###end title 86
###begin p 87
Prior to burning the CA sample was subjected to UV/ozone radiation for 10 min and then was burned at 350degreesC in an ashing furnace (Carbolite) for 4x30 min. The gradually decreasing weight of CA was measured by using AE100 microbalances (Mettler Toledo) with an accuracy of six digits after each time interval until the weight remained constant.
###end p 87
###begin title 88
Supporting Information
###end title 88
###begin p 89
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
###xml 74 81 <span type="species:ncbi:9606">patient</span>
PCR analysis of CA inclusions. Escherichia coli 16s rDNA detected in five patient specimens are shown in lines (1-5), negative control - in line (6), phiX174 RF DNA marker - in line (7).
###end p 89
###begin p 90
(0.14 MB JPG)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
Congo red staining of CA. CA inclusions were stained with Congo red and observed in polarized microscope with 40-fold magnification.
###end p 92
###begin p 93
(0.09 MB JPG)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
We thank Drs. D. Bostrom, A. Gharibyan and J. Loring, Umea University for their able technical assistance.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
Benign prostatic hyperplasia: age-related tissue-remodeling.
###end article-title 97
###begin article-title 98
Inflammation in prostate carcinogenesis.
###end article-title 98
###begin article-title 99
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
###end article-title 99
###begin article-title 100
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
###end article-title 100
###begin article-title 101
Inflammation and cancer.
###end article-title 101
###begin article-title 102
Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images.
###end article-title 102
###begin article-title 103
Corpora amylacea in adenocarcinoma of the prostate: incidence and histology within needle core biopsies.
###end article-title 103
###begin article-title 104
Architectural patterns of high-grade prostatic intraepithelial neoplasia.
###end article-title 104
###begin article-title 105
###xml 46 51 <span type="species:ncbi:9606">human</span>
S100 proteins in Corpora amylacea from normal human brain.
###end article-title 105
###begin article-title 106
Corpora amylacea in the lung, prostate and uterus. A comparative and immunohistochemical study.
###end article-title 106
###begin article-title 107
Corpora amylacea in a mature cystic teratoma of the ovary.
###end article-title 107
###begin article-title 108
X-ray microprobe analysis of corpora amylacea.
###end article-title 108
###begin article-title 109
Heat shock protein 60 in corpora amylacea.
###end article-title 109
###begin article-title 110
Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains.
###end article-title 110
###begin article-title 111
Corpora amylacea: a marker for mesial temporal sclerosis.
###end article-title 111
###begin article-title 112
Corpora amylacea could be an indicator of neurodegeneration.
###end article-title 112
###begin article-title 113
Amyloid in prostatic corpora amylacea.
###end article-title 113
###begin article-title 114
The x-ray diffraction pattern of prostatic corpora amylacea.
###end article-title 114
###begin article-title 115
Prostatic corpora amylacea. A study with the electron microscope and electron probe.
###end article-title 115
###begin article-title 116
Prostatic calculi: a review.
###end article-title 116
###begin article-title 117
Prostatic calculi.
###end article-title 117
###begin article-title 118
Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?
###end article-title 118
###begin article-title 119
Localized amyloidosis of seminal vesicle and vas deferens: report of two cases.
###end article-title 119
###begin article-title 120
Localized primary amyloidosis of the prostate, bladder and ureters.
###end article-title 120
###begin article-title 121
Unreliability of immunohistochemistry for typing amyloid deposits.
###end article-title 121
###begin article-title 122
The S100 family of EF-hand calcium-binding proteins: functions and pathology.
###end article-title 122
###begin article-title 123
New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family.
###end article-title 123
###begin article-title 124
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation.
###end article-title 124
###begin article-title 125
S100A8 and S100A9 in inflammation and cancer.
###end article-title 125
###begin article-title 126
Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis.
###end article-title 126
###begin article-title 127
S100 proteins and their influence on pro-survival pathways in cancer.
###end article-title 127
###begin article-title 128
Pathologies involving the S100 proteins and RAGE.
###end article-title 128
###begin article-title 129
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
###end article-title 129
###begin article-title 130
###xml 74 79 <span type="species:ncbi:9606">human</span>
Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
###end article-title 130
###begin article-title 131
###xml 108 113 <span type="species:ncbi:9606">human</span>
S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
###end article-title 131
###begin article-title 132
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.
###end article-title 132
###begin article-title 133
###xml 21 26 <span type="species:ncbi:9606">human</span>
S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.
###end article-title 133
###begin article-title 134
Molecular basis of the complex formation between the two calcium-binding proteins S100A8 (MRP8) and S100A9 (MRP14).
###end article-title 134
###begin article-title 135
Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
###end article-title 135
###begin article-title 136
Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations.
###end article-title 136
###begin article-title 137
The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
###end article-title 137
###begin article-title 138
Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service.
###end article-title 138
###begin article-title 139
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
###end article-title 139
###begin article-title 140
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.
###end article-title 140
###begin article-title 141
###xml 69 75 <span type="species:ncbi:9796">equine</span>
Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?
###end article-title 141
###begin article-title 142
Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways.
###end article-title 142
###begin article-title 143
###xml 43 48 <span type="species:ncbi:9606">human</span>
Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins.
###end article-title 143
###begin article-title 144
Prediction of aggregation-prone regions in structured proteins.
###end article-title 144
###begin article-title 145
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
###end article-title 145
###begin article-title 146
###xml 44 49 <span type="species:ncbi:9606">human</span>
Two-dimensional electrophoretic analysis of human prostatic fluid proteins.
###end article-title 146
###begin article-title 147
###xml 76 81 <span type="species:ncbi:9606">human</span>
A comprehensive characterization of the peptide and protein constituents of human seminal fluid.
###end article-title 147
###begin article-title 148
###xml 13 29 <span type="species:ncbi:562">Escherichia coli</span>
Detection of Escherichia coli 16S RNA and cytotoxic necrotizing factor 1 gene in benign prostate hyperplasia.
###end article-title 148
###begin article-title 149
###xml 29 45 <span type="species:ncbi:562">Escherichia coli</span>
Urovirulence determinants in Escherichia coli strains causing prostatitis.
###end article-title 149
###begin article-title 150
###xml 35 51 <span type="species:ncbi:562">Escherichia coli</span>
Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance.
###end article-title 150
###begin article-title 151
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.
###end article-title 151
###begin article-title 152
Inflammation in neurodegenerative disease-a double-edged sword.
###end article-title 152
###begin article-title 153
The significance of neuroinflammation in understanding Alzheimer's disease.
###end article-title 153
###begin article-title 154
Immunological features of alpha-synuclein in Parkinson's Disease.
###end article-title 154
###begin article-title 155
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
###end article-title 155
###begin article-title 156
Amyloid-like fibril formation of co-chaperonin GroES: nucleation and extension prefer different degrees of molecular compactness.
###end article-title 156
###begin article-title 157
We find them here, we find them there: functional bacterial amyloid.
###end article-title 157
###begin article-title 158
Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
###end article-title 158
###begin article-title 159
###xml 0 27 <span type="species:ncbi:10298">Herpes simplex virus type 1</span>
Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection.
###end article-title 159
###begin article-title 160
###xml 50 53 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Semen-derived amyloid fibrils drastically enhance HIV infection.
###end article-title 160
###begin article-title 161
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.
###end article-title 161
###begin article-title 162
###xml 36 42 <span type="species:ncbi:9606">humans</span>
Functional amyloid-from bacteria to humans.
###end article-title 162
###begin article-title 163
Amyloids: not only pathological agents but also ordered nanomaterials.
###end article-title 163
###begin article-title 164
###xml 111 116 <span type="species:ncbi:4932">yeast</span>
Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.
###end article-title 164
###begin article-title 165
Formation of amyloid fibers triggered by phosphatidylserine-containing membranes.
###end article-title 165
###begin article-title 166
###xml 44 49 <span type="species:ncbi:9606">human</span>
Protein misfolding, functional amyloid, and human disease.
###end article-title 166
###begin article-title 167
Protein misfolding, evolution and disease.
###end article-title 167
###begin article-title 168
###xml 81 86 <span type="species:ncbi:9606">human</span>
Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils.
###end article-title 168
###begin article-title 169
Highly selective enrichment of phosphorylated peptides using titanium dioxide.
###end article-title 169
###begin article-title 170
###xml 38 58 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Purification of a plant mediator from Arabidopsis thaliana identifies PFT1 as the Med25 subunit.
###end article-title 170
###begin article-title 171
###xml 56 62 <span type="species:ncbi:9796">equine</span>
Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration.
###end article-title 171
###begin article-title 172
###xml 50 55 <span type="species:ncbi:9606">human</span>
Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
###end article-title 172
###begin article-title 173
###xml 55 72 <span type="species:ncbi:1423">Bacillus subtilis</span>
Surface characterization of the Gram-positive bacteria Bacillus subtilis an XPS study.
###end article-title 173
###begin p 174
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 174
###begin p 175
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research and L.A.M-R. were supported by the Swedish Medical Research Council and by grants from the Kempe Foundation, Sweden.
###end p 175

